SAN MATEO, Calif. (AP) ¿ Biotech drugmaker NeurogesX Inc. said Tuesday it regained compliance with Nasdaq Stock Market rules after naming a new member to its audit committee.
Companies listed on the Nasdaq must have at least three members on their audit committees, all of them independent directors. NeurogesX said the appointment of Bradford Goodwin to the board brings it back into compliance with that rule.
Goodwin was named to the board and to the role of chairman of the audit committee, effective Aug. 20. NeurogesX had been in violation of the rule since July 14, when Bruce Peacock resigned from the committee.
In morning trading, shares of NeurogesX lost a penny to $7.24.